» Articles » PMID: 15996912

Application of the Platelet Count/spleen Diameter Ratio to Rule out the Presence of Oesophageal Varices in Patients with Cirrhosis: a Validation Study Based on Follow-up

Overview
Journal Dig Liver Dis
Publisher Elsevier
Specialty Gastroenterology
Date 2005 Jul 6
PMID 15996912
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Screening for oesophageal varices represents an important part of the diagnostic work-up of cirrhotic patients. We have previously shown that the platelet count/spleen diameter ratio is a parameter that can rule out the presence of oesophageal varices safely and in a cost-effective fashion.

Aim: To evaluate the prognostic and diagnostic accuracy of the platelet count/spleen diameter ratio for ruling out the presence of oesophageal varices in the follow-up of a cohort of cirrhotic patients without oesophageal varices at inclusion.

Methods: After initial endoscopy, the 106 cirrhotic patients without oesophageal varices who participated in our previous study were followed-up with annual or biannual surveillance endoscopy. Patients were censored at the time of diagnosis of oesophageal varices or at their last visit, and at that time platelet count and spleen diameter were recorded. Sixty-eight patients made up the study cohort after excluding patients who were lost to follow-up or died before undergoing control endoscopy.

Results: During the follow-up, 27 patients (40%) developed oesophageal varices. Patients with higher baseline platelet count/spleen diameter ratios (p<0.0001) as well as a ratio above 909 were less likely to develop oesophageal varices (p<0.0005). At follow-up, a platelet count/spleen diameter ratio < or = 909 had 100% negative predictive value and 84% efficiency in identifying the presence of oesophageal varices.

Conclusions: The use of the platelet count/spleen diameter ratio proved to be an effective means for ruling out the presence of oesophageal varices even in the longitudinal follow-up of patients.

Citing Articles

Platelet counts to spleen diameter ratio: A promising noninvasive tool for predicting esophageal varices in cirrhosis patients.

Mossie G, Nur A, Ayalew Z, Azibte G, Berhane K World J Hepatol. 2024; 16(10):1177-1187.

PMID: 39474572 PMC: 11514619. DOI: 10.4254/wjh.v16.i10.1177.


Impact of sustained virologic response in regression of portal hypertension in Egyptian patients with hepatitis C virus-associated cirrhosis and portal hypertension.

Faheem H, Abdulmeged N, Hussein H, Elmoursi A, Elnaggar H, Ghait R Egypt Liver J. 2022; 12(1):27.

PMID: 35433052 PMC: 8990271. DOI: 10.1186/s43066-022-00188-x.


Platelet count/spleen volume ratio has a good predictive value for esophageal varices in patients with hepatitis B liver cirrhosis.

Yu S, Chen W, Jiang Z PLoS One. 2021; 16(12):e0260774.

PMID: 34855845 PMC: 8638864. DOI: 10.1371/journal.pone.0260774.


Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure.

Frangakis C, Sohn J, Bas A, Chapiro J, Schernthaner R, Lin M Front Oncol. 2021; 11:639235.

PMID: 34804911 PMC: 8602787. DOI: 10.3389/fonc.2021.639235.


Role of non-invasive markers in prediction of esophageal varices and variceal bleeding in patients of alcoholic liver cirrhosis from central India.

Kothari H, Gupta S, Gaikwad N, Sankalecha T, Samarth A Turk J Gastroenterol. 2019; 30(12):1036-1043.

PMID: 31854309 PMC: 6924602. DOI: 10.5152/tjg.2019.18334.